For the identification and authentication of human cell lines and the detection of cross-contamination within the same cell line!
Our company offers a cell line authentication (STR analysis) contract analysis service. We determine the STR (short tandem repeat) genotype from samples derived from human cultured cells. We use the GenePrint® System (10 loci) or the PowerPlex® 16 System (16 loci). Please use this service for the identification and authentication of human cell lines, as well as for detecting cross-contamination within the same type of cell lines. 【Features】 - Determine STR genotype from samples derived from human cultured cells. - Use the GenePrint® System, which is suitable for the identification and authentication of human cell lines and for detecting cross-contamination within the same type of cell lines. - Use the PowerPlex® 16 System, which is suitable for confirming the genotype of iPS/ES cells. - We can provide a free English report for customers who wish to submit it for publication. *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【GenePrint(R) System 10 Locus Content】 ■ A system designed for the easy identification and authentication of human cell lines, as well as the detection of cross-contamination within cell line types. ■ D21S11, D16S539, D7S820, D13S317, D5S818, CSF1PO, TPOX, TH01, vWA, Amelogenin 【PowerPlex(R) 16 System 16 Locus Content】 ■ A system designed for the easy performance of DNA typing, including paternity testing, forensic DNA analysis, individual identification tests, and cell line identification. ■ GenePrint's 10 loci + D18S51, D3S1358, FGA, D8S1179, Penta D, Penta E * For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■ Contract analysis service for cell line authentication (STR analysis) *For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Bex Corporation focuses on the development, manufacturing, and sales of gene introduction devices based on electroporation, such as "CUY21," and cell fusion, nuclear fusion, and oocyte activation devices like "LF." Particularly in in vivo electroporation, we have established various applications, including electrode fabrication, contributing to researchers worldwide. Additionally, in our contract research services, we provide high-quality services as a "second lab" for researchers, including oligo DNA synthesis, peptide synthesis, antibody production, gene analysis, and genetic engineering experiments. By connecting all these services in a one-stop manner, we are able to offer fast and high-quality services.
